|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Matthew Shick |
Date | 1/23/2017 3:21:24 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Issue: Support the use of animals in medical research.
H.R. 3136, Enforcement Transparency Act of 2015
Issue: Support transparency in the enforcement of the Animal Welfare Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Clayton |
Crabtree |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Presidents Budget, FY 2017
S. 3040/H.R. 5916 Labor, HHS, Education and Related Agencies Act, 2017, Title II
Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose rescissions from the Center for Medicare and Medicaid Innovation and Patient Centered Outcomes Research Trust Fund. Oppose additional continuing resolutions.
President's Budget, FY 2017
Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy.
President's Budget, FY 2017
P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issues: Support funding for Veterans Affairs medical research, research infrastructure, and community care.
S. 289/H.R. 2104, American Cures Act
Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program
S. 318/H.R. 531, Accelerating Biomedical Research Act
Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH).
H.R. 777, Permanent Investment in Health Research Act
Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation.
S. 2624, National Biomedical Research Act.
Issue: Support establishment of a Biomedical Innovation Fund to support the National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending.
P.L. 114-74, H.R. 1314, Bipartisan Budget Act of 2015
Issue: Oppose Medicare site-neutral payment policy. Oppose extension of Medicare sequester
Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issue: Support supplemental funding to prevent and combat Zika virus; Oppose use of other health funding to offset Zika investments
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Courtney |
Summers |
|
|
|
Clayton |
Crabtree |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 9, Innovation Act
S. 1137, Protecting American Talent and Entrepreneurship (PATENT) Act
S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016
Issue: Support patent-litigation reform to curtail abusive patent practices. Oppose presumptive fee-shifting and involuntary joinder in light of recent judicial and administrative developments.
Submitted comments to:
--the National Institutes of Standards and Technology (NIST) on rights to federally funded inventions and licensing of government owned inventions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Presidents Budget, FY 2017
Issues: Oppose cuts to graduate/professional student loan benefits, including Public Service Loan Forgiveness (PSLF). Oppose taxation of federal loan repayment programs.
Draft Debt in Health Education Loan Programs (DebtHELP) legislative proposal
Issues: Expand National Health Service Corps State Loan Repayment program, and align Department of Education and HRSA student loan programs.
Draft Higher Education Act Reauthorization
S. 108, Financial Aid Simplification and Transparency Act of 2014 (FAST Act)
S. 85, Repay Act of 2015
Issues: Oppose cuts to graduate/professional student loan benefits, including Public Service Loan Forgiveness (PSLF). Support transparency for U.S. and international medical schools.
H.R. 4223, POST GRAD Act
Issue: Support restoring the interest subsidy on graduate and professional student loans
Issue: Support global health learning opportunities
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issue: Educate congressional staff on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.
Issue: Support enactment of simultaneous repeal and replace of Affordable Care Act. Support continuation high-quality affordable health insurance through preservation of ACA health care coverage including private market insurance and Medicaid expansion. Support programs and funds for safety-net providers until replace is ready
Issue: Support inclusion of socioeconomic status in Hospital Compare star ratings; delay public release of ratings until data is released and reviewed by hospital community.
H.R. 1006/S. 2107, Building a Health Care Workforce for the Future Act
Issue: Support bill to increase scholarship opportunities for medical students and encourage primary care workforce development Issue: Reauthorization of Title VII health professions programs
Issue: Diversity of the health care workforce
Issue: Training in substance abuse, pain management, womens health, and mental health in medical education Issue: Strategies to prevent, identify, and treat opioid dependence
Issue: Concurrent and overlapping surgery practices
S. 1455, TREAT Act
Issue: Support legislation to expand cap on buprenorphine
Issue: Provide comments on draft legislation to increase the safety of prescription drug use
H.R. 4499, Promoting Responsible Opioid Prescribing Act of 2016
Issue: Support delinking the Hospital Consumer Assessment of Healthcare Providers and Systems surveys pain management questions from the Centers for Medicare and Medicaid Services calculations of hospital incentive payments under the Value-Based Purchasing Program.
Issue: Implementation of 340B Drug Pricing Program and eligibility of offsite facilities under OPPS
Issue: Educate Congress on the impact of the self-referral (Stark law) on health care payment and delivery system reform, and how to promote development of alternative payment models
S. 2837/H.R. 2578, FY 2017 Commerce-Justice-Science Appropriations
Issue: Support amendments to expand background checks on gun purchases and make it more difficult for known/suspected terrorists to purchase firearms.
H.R. 3299, Strengthening Public Health Emergency Response Act of 2015 Issue: Support provisions to strengthen the Hospitals Preparedness Program
Issue: Educate Congress on the role of Academic Medical Centers in emergency preparedness
Submitted comments to:
-- HRSA on the 340B Drug Pricing Program; Administrative Dispute Resolution; Notice of Proposed Rulemaking
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Agriculture - Dept of (USDA), Commerce - Dept of (DOC), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Clayton |
Crabtree |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 1189, Conrad State 30 and Physician Access Act
Issue: Support permanently reauthorization and expansion of the Conrad 30 J-1 visa waiver program for physicians.
Issue: Support policies allowing undocumented students to attend U.S. medical schools and residency training. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement, such as the Development, Relief, and Education for Alien Minors (DREAM) Act. Support DREAMer eligibility for federal student loans.
S.3542, Bar Removal of Individuals who Dream and Grow our Economy (BRIDGE) Act
Issue: Support provisional protected presence for DACA eligible individuals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Issue: Oppose False Claims Act use as a general enforcement mechanism for regulatory compliance, particularly administrative requirements related to participation in the Medicare program as opposed to payment requirements.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
P.L. 114-255, 21st Century Cures Act
Issue: Support increased funding for medical research, reduce administrative and regulatory burden on scientists and research institutions, and support young investigators. Oppose reduction in Medicare hospital outpatient department reimbursement. Support incorporating sociodemographic status in Hospital Readmissions Reduction Program and addressing mid-build, off-campus outpatient departments under development at the time of enactment of the Bipartisan Budget Act of 2015. Create a crosswalk between Medicare Part A and Part B payments.
Issue: Support federal funding for research using fetal tissue and promote security of individuals involved with fetal tissue research.
H.R. 3466/S. 2014, Next Generation Research Act
Issue: Support National Institutes of Health programs for new and young scientists, reauthorization of NIH loan repayment program.
H.R. 2102, Research for All Act of 2015
Issue: Support inclusion of male and female cells and animals in basic research, and NIH updating its guidelines on inclusion of women in clinical research.
S. 2742, Promoting Biomedical Research and Public Health for Patients Act. Issue: Support reducing regulatory burden on research institutions and scientists.
Issue: Support NIHs protection of researchers from sexual harassment Issue: FDA regulation of Laboratory Developed Tests (LDTs)
Issue: Support NIH medical research of pain and addiction
S. 2953, FY 2017 National Defense Authorization Act
Issue: Oppose restrictions on medical research supported by the Department of Defense
Submitted comments to:
--NIH on the use of preprints and interim research products in NIH applications and reports.
--NIH on the use of a single Institutional Review Board (sIRB) for multi-site research.
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), Labor - Dept of (DOL), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Clayton |
Crabtree |
|
|
|
Len |
Marquez |
|
|
|
Courtney |
Summers |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act of 2015
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments
H.R. 4774, The Training Tomorrows Doctors Today Act
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments. Increases transparency and accountability measures.
Issue: Oppose reduction of Medicare GME/IME payments
Issue: Oppose inclusion of Medicare add-on payments in Hospital-Acquired Condition (HAC) program. Issue: Oppose Medicare hospital cuts as offsets for physician payment reform
Issue: Support delay of Enforcement of new Centers for Medicare and Medicaid Services inpatient criteria (e.g., "Two-Midnight" rule) in FY 2016 Inpatient Prospective Payment System (IPPS) final rule.
H.R. 4732/S.2671, Advancing Medical Resident Training in Community Hospitals Act
Issue: Support Medicare Graduate Medical Education (GME) per resident amount technical corrections and administrative relief.
H.R. 5273, Helping Hospitals Improve Patient Care Act of 2016
Issue: Support incorporating sociodemographic status Hospital Readmissions Reduction Program and addressing mid-build, off-campus outpatient departments under development at the time of enactment of the Bipartisan Budget Act of 2015.
H.R. 1343/S. 688, Establishing Beneficiary Equity in the Hospital Readmissions Program Act of 2015 Issue: Support inclusion of socioeconomic status as part of hospital readmissions program.
H.R. 3288, Strengthening DSH and Medicare through Subsidy Recapture and Payment Reform Act of 2015 Issue: Alter DSH payment methodology and increase DSH spending in non-Medicaid expansion states
S. 2787, the States Achieve Medicaid Expansion (SAME) Act
Issue: Support legislation providing three full years of federal Medicaid matching funding to states that expand Medicaid
H.R. 3292, Medicare IME Pool Act of 2015
Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.
H.R. 3291, Medicare Crosswalk Hospital Code Development Act of 2015 Issue: Create a crosswalk between Medicare Part A and Part B payments
P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015.
Issues: Support repeal of Medicare's sustainable growth rate (SGR) formula; Medicare physician payment reform; extension of the Childrens Health Insurance Program (CHIP); and extension of mandatory funding for the National Health Service Corps (NHSC).
H.R. 1117, Creating Access to Residency Education Act of 2015 Issue: Create CMS grant program for new residency programs.
Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the ACA. Draft Hospital Improvements for Payment (HIP) Act of 2014
Issues: Support repeal of CMS Two-Midnights Rule, extending RAC audit moratorium for short stays, and permanent bundle program.
Issue: Oppose further delays in the implementation of the ICD-10 system
Issue: Support inclusion of socioeconomic status as part of hospital readmissions program including support for adoption of National Quality Forum (NQF) recommendations.
Issue: Support allowing providers in new delivery models (e.g., ACOs, bundled payments, etc.) to access medical records with information on substance use disorders
H.R. 6088, Hospital Quality Rating Transparency Act of 2016
Issue: delay release of CMS Hospital Compare Star Ratings to give stakeholders time to work together to address concerns with methodology.
Submitted comments to:
--CMS on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) final rule, including the Merit-Based Incentive Payment Systems (MIPS) and Alternative Payment Model (APM) Incentive
--CMS on key proposals issued in the Episode Payment Models (EPMs) proposed rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Courtney |
Summers |
|
|
|
Tannaz |
Rasouli |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Issue: Support the use of a competitive peer review process for federal research grants and programs
Issue: Oppose Increase in set-aside for Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (SITR) at NIH and NSF.
S. 3084, American Innovation and Competitiveness Act
Issue: Support reauthorization of NSF, including NSFs merit-bases peer review process and reducing regulatory burden on scientists
Submitted comments to:
--the Commission on Evidence-Based Policymaking on the impact, feasibility, and necessity of using available and newly collected data to propose, implement, and evaluate government programs and policies.
-- OMB on the Statistical Policy Directive on Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
RASOULI |
|
|
|
Clayton |
Crabtree |
|
|
|
Karen |
Fisher |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
P.L. 114-41, Surface Transportation and Veterans Health Care Choice Improvement Act of 2015 Issue: Support improved contracting with academic affiliates and increased VA GME funding.
S. 1676/H.R. 4011, Delivering Opportunities for Care and Services (DOCs) for Veterans Act
H.R. 3755, To amend title XVIII of the Social Security Act to provide for the disregard of certain resident slots that include Department of Veterans Affairs training in determining payments for direct graduate medical education costs, and for other purposes.
Issue: Support increased VA GME and Medicare GME funding for certain VA affiliates
H.R. 3879, Enhanced Veterans Health Care Act
Issue: Support VA authority for VA-academic joint ventures
S. 2633, Improving Veterans Access to Care in the Community Act
Issue: Support VA Plan to Consolidate Community Care Programs, including the proposed Core Network and sole source contracting with academic affiliates.
Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships.
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Len |
Marquez |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Clayton |
Crabtree |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S.2707/H.R. 4773, Protecting Workplace Advancement and Opportunity Act
Issue: Support NIH stipend as threshold for Fair Labor Standards Act employee overtime and exemption of postdoctoral scientists as learned professionals
17. House(s) of Congress and Federal agencies Check if None
Labor - Dept of (DOL), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |